Plain-English translation of NCT07335796 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether BMS986365, a new drug, works well and is safe when combined with a hormone therapy called in men with high-risk localized prostate cancer. The two medications would be given before you have surgery to remove your prostate. The study wants to find out if this treatment combination helps and causes manageable side effects.
High-risk prostate cancer is more aggressive and harder to treat with surgery alone. Doctors are studying whether giving this medication before surgery can help improve outcomes and give patients the best chance of staying cancer-free.
You would receive the hormone therapy () and take the new medication (BMS986365) for a period of time before your scheduled prostate surgery. You'll have regular visits to your doctor for blood tests, check-ups, and monitoring of how you're responding to the treatment. The study is small, with about 7 participants, and your doctor will be watching closely to make sure the medications are working safely.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States